Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SkyePharma licenses European Depocyte rights to Mundipharma

July 23, 2003

Antitumor activity of the novel coxib CS-706 (R-109339) in mice

July 23, 2003

U. of Oklahoma researchers identify novel proapoptotic antitumor compounds

July 23, 2003

Small-molecule inhibitor of IGF-IR kinase activity characterized at cancer meeting

July 22, 2003

CanBas identifies peptide with the ability to abrogate the G2 cell cycle checkpoint

July 22, 2003

Small-molecule Bcl-xL/Bcl-2 antagonist with potential for combination therapy

July 22, 2003

AACR news: agonist antibodies to TRAIL-R2 show promise for the treatment of cancer

July 22, 2003

Glivec approved in Japan for KIT (CD117)-positive GIST

July 22, 2003

Cuban researchers identify CKII inhibitors with potential in cancer therapy

July 22, 2003

CDK2/CDK4 inhibitors prepared and tested by GSK researchers

July 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...